Standard

Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses

The International Genomics Consortium’s (IGC) Expression Project for Oncology (expO) has released clinically annotated gene expression profiles for 60 tumor specimens, completing the initial phase of the nation’s first and eventually largest public database dedicated to standardized gene expression data. The clinically annotated dataset is available in the public domain through the National Cente...

Carnegie Mellon U. transforms DNA microarrays with standard Internet communications tool

A standard Internet protocol that checks errors made during email transmissions has now inspired a revolutionary method to transform DNA microarray analysis, a common technology used to understand gene activation. The new method, which blends experiment and computation, strengthens DNA microarray analysis, according to its Carnegie Mellon University inventor, who is publishing his findings in the...

Setting the standard for computer models of life

Biologists are making a concerted effort to catalogue all the molecular components of living things, from the smallest molecules and ions to the genetic code. These 'parts lists' help them to build computer models that simulate living processes. By combining models of simple processes they hope to understand and faithfully represent how entire biological systems - be they cells, organs, o...

Results with newer bladeless LASIK equivalent to standard microkeratome LASIK

A Mayo Clinic study comparing femtosecond (bladeless) and mechanical microkeratome LASIK surgeries has found equal results from both types six months post-surgery, using a variety of vision and eye health measurements. The study's findings will be presented next week in three abstracts at the Association for Research in Vision and Ophthalmology meeting in Fort Lauderdale, Fla. LASIK (Lase...

DOE JGI sets 'gold standard' for metagenomic data analysis

With the advent of more powerful and economical DNA sequencing technologies, gene discovery and characterization is transitioning from single-organism studies to revealing the potential biotechnology applications embedded in communities of microbial genomes, or metagenomes. The field of metagenomics is still in its infancy -- the equivalent of the early days of the California Gold Rush, with lab...

Standard at Biology Products

Standard Protein Kinase Substrate (PKS) Peptide Microarray from LC Sciences

Description:Microarrays designed for proteomic scale kinase profiling, quantitative measurement of kinase kinetic activities, and drug discovery research built on the flexible and powerful Paraflo microfluidic on-chip synthesis platform. These microarrays are available as part of our comprehensive Protein Kinase Substrate - Peptide Microarray Service. Our standard content PKS...
Company:LC Sciences

Standard DNA Aptamer Microarray from LC Sciences

Description:Microarrays designed for DNA aptamer screening and binding optimization and built on the flexible and powerful Paraflo microfluidic on-chip synthesis platform. These microarrays are available as part of our comprehensive DNA/RNA Aptamer Microarray Service. Our Standard DNA Aptamer Microarray contains greater than 1500 known aptamer sequences. Add up to 100 of your o...
Company:LC Sciences

Standard 2'-F RNA Aptamer Microarray from LC Sciences

Description:Microarrays designed for RNA aptamer screening and binding optimization and built on the flexible and powerful Paraflo microfluidic on-chip synthesis platform. These microarrays are available as part of our comprehensive DNA/RNA Aptamer Microarray Service. Our Standard 2-F RNA Aptamer Microarray contains greater than 1500 known aptamer sequences. Add up to 100 of yo...
Company:LC Sciences

Standard 2'-OMe RNA Aptamer Microarray from LC Sciences

Description:Microarrays designed for RNA aptamer screening and binding optimization and built on the flexible and powerful Paraflo microfluidic on-chip synthesis platform. These microarrays are available as part of our comprehensive DNA/RNA Aptamer Microarray Service. Our Standard 2-OMe RNA Aptamer Microarray contains greater than 1500 known aptamer sequences. Add up to 100 of...
Company:LC Sciences

Illumina Standard Data Analysis Report from Asuragen, Inc.

Description:Maximize the value of your microarray data using Asuragens bioinformatics expertise. We offer the support you need from consultation to extensive data analysis using the most up to date methods. Utilize our expertise in combination with the Gene Expression Profiling Service or from your own microarray experiments. Raw data report from Illumina Sentra BeadChip...
Company:Asuragen, Inc.

More>>

Standard at Biology Technology

Brinkmann/Eppendorf SOP Standard Operating Procedure for Pipettes

SOP Standard Operating Procedure for Pipettes Testin...

BioRobot MDx standardize your automated protocols in clinical laboratories

The BioRobot MDx is the latest addition to the range of BioRobot workstations and is designed to meet the needs of scientists requiring standardized protocols in environments such as clinical testing laboratories....

Verifying Multichannel Pipettor Performance with Standard Dispense Solutions in the SpectraMax Plus (MaxLine Application Note #28)

Pipettors often fail to meet the manufacturers stated specifications and pipetting is a major source of laboratory error even when the pipettor is operating properly. Accuracy and precision specifications typically provided by pipettor manufacturers are obtained under ideal conditions. In the laboratory, performan...

Standard Imaging acquires Canadian PIPSpro radiation treatment technologies

Middleton, Wis. s assets. Among the assets acquired from the British Colum...

Standard Imaging acquires Canadian PIPSpro radiation treatment technologies

Middleton, Wis. assets. Among the assets acquired from the British Colu...

More>>

Standard at Medicine News

New standards for Human Research Safety

Joint Commission on Accreditation of Health Care Organizations and the National Committee for Quality Assurance recently announced plans to set up a program to review the safety of clinical tests// in humans. This announcement came close on the heels of U.S. officials moving to suspend gene therapy studies pending an investigation of side effects in a French study, which found a cure for "bubble...

Angioplasty Should be the Standard

A new study finds angioplasty should be the treatment of choice for heart attack patients, even if the hospital they initially //go to doesn't offer angioplasty services and they have to be transferred to another facility for treatment. Research has shown heart attack patients fare better when they are treated with angioplasty to open up the clogged blood vessel that caused the attack th...

Presence of substandard drugs can pose concern for patients

German scientists have found out that the drug streptokinase used in many non-European countries //are not up to the standard, as the amount of streptokinase present in the preparation is really low. The study, which had tested 16 different forms of streptokinase medications across the European continent, has found only three formulations that match the safety and quality standards.<br...

Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices

The Central Drugs Standard Control Organisation (CDSCO) in India has decided to prepare a set of guidelines for uniform action against the manufacture// of not of standard quality (NSQ) medical devices, diagnostic reagents, diagnostic kits etc. The guidelines drawn out would prescribe the exact procedures to be followed and action to be taken against the manufacturers by every state drug controll...

Researchers Feel The Need For Standards Of Practice In Immunoglobulin Therapy

Nursing specialists feel that there is a requirement for having a standard of practice in immunoglobulin therapy. A review article published in the July/August 2005 Journal of Infusion Nursing examines the need for established treatment guidelines // to support doctors and nurses in correctly dosing and administering intravenous immunoglobulin (IVIG) as replacement therapy in patients w...

More>>

Standard at Medicine Products

The Protract Hip System - Protract Standard Hip Stem

Description:The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Company:StelKast Company

The Progeny Hip System - Progeny Cemented Standard Stem

Description:The Progeny femoral stem offers a cemented option built upon a clinically proven design. Standard and lateralized offsets are available to allow interoperative soft tissue balancing without compromising leg length....
Company:StelKast Company

MPF cup - Standard (Zero Hole)

Description:The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
Company:Plus Orthopedics

LM-101 Standard Lensmeter

Description:The Marco Lensmeter 101 is well suited for measuring soft and hard contact lenses as well as conventional spectacle lenses. It is a compact deluxe model with a full 90-degree inclination, which facilitates the measurement of contact lenses when used in the vertical position. The instrument is well suited for laboratory or office use....
Company:Marco Ophthalmic, Inc.

LM-201 Standard Lensmeter

Description:The Marco Lensmeter 201 features internal readings for the presbyopic practitioner or those who prefer to work in subdued lighting where external readings are difficult....
Company:Marco Ophthalmic, Inc.

More>>

Standard at Medicine Technology

RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments

IRVING, Texas--(BUSINESS WIRE)--Jun 29, 2007 - ReataPharmaceuticals, Inc. today announced the presentation of newpreclinical data showing their lead anti-cancer agent, theSynthetic Triterpenoid RTA 402, is effective at protecting againstcommon toxicities caused by traditional cancer treatments. Thisdata was presented at the annual meeting of the MultinationalAssociation of Supportive Care i...

Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care

NUTLEY, N.J., June 15, 2007 /PRNewswire/ -- Results of theOption (TOcilizumab Pivotal Trial in Methotrexate InadequaterespONders) trial, the first multinational Phase III study outsideof Japan, showed that patients treated with Actemra (either 4mg/kgor 8mg/kg) plus methotrexate achieved a significant and clinicallyimportant improvement in the signs and symptoms of moderate tosevere rheum...

Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care

THE WOODLANDS, Texas--(BUSINESS WIRE)--Jun 11, 2007 - ReprosTherapeutics Inc. (NasdaqGM:RPRX) today released top-line findingsfrom its six month study of Proellex in the treatment ofendometriosis. This study, conducted in Europe, enrolled 39premenopausal women and has completed six months of dosing. Thestudy included three dose levels of Proellex(TM) as well as apositive control arm. The po...

Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a Phase II Trial

~ Valopicitabine achieved both primary and secondary endpoints ofstudy; no negative drug-drug interaction was observed betweenvalopicitabine and ribavirin ~ CAMBRIDGE, Mass., June 12, 2007 /PRNewswire-FirstCall/ -- IdenixPharmaceuticals, Inc. today announced results from a phase II studydesigned to evaluate triple combination therapy, consisting ofvalopicitabine (NM283), Idenix's lead dru...

Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death

"Patients and physicians should find these data reassuring" PHILADELPHIA, June 05, 2007 /PRNewswire-FirstCall/ --GlaxoSmithKline said today that findings from an interim analysisof RECORD (Rosiglitazone Evaluated for Cardiac Outcomes andRegulation of glycemia in Diabetes), a prospective clinical trialdesigned specifically to determine cardiovascular outcomes in morethan 4,400 patients wit...

More>>